جستجوی استاد راهنمای دانشگاهی

ORHAN ZENGİNمشاهده پروفایل

دانشیار

• Rheumatology
• Internal Medicine
• Behçet's Disease
• +۷ مورد دیگر

Orhan Zengin is an Associate Professor at Gaziantep University Faculty of Medicine, Department of Internal Medicine, specializing in Rheumatology. He has held this position since 2021, following previous roles as a Research Assistant at the same institution from 2007-2012 and 2014-2017. His academic journey began with a Medical License from Firat University Faculty of Medicine (2001-2007), followed by Medical Specialization in Internal Medicine at Gaziantep University (2007-2012), and further subspecialty training in Rheumatology (2014-2017). Dr. Zengin has also served in external roles as a Specialist Doctor at the Ministry of Health Ersin Arslan State Hospital (2019-2021) and completed mandatory service at the Ministry of Health (2017-2019). He is an active member of the Turkish Rheumatology Association since 2014 and holds an EULAR Ultrasonography certificate (intermediate level). His research focuses on Rheumatology with particular emphasis on Behçet's disease, Spondyloarthritis, Rheumatoid arthritis, Autoimmune diseases, Vasculitis, and Fibromyalgia. A distinctive aspect of his work involves analyzing the quality of medical information on YouTube, with multiple publications examining this digital health education resource for conditions like psoriatic arthritis, osteoporosis, gout, and biologic therapy side effects. Dr. Zengin has published 41 peer-reviewed articles in international and national journals, along with 3 book chapters on rheumatic diseases. His research demonstrates strong clinical relevance with significant contributions to understanding disease patterns in Turkish populations. He has supervised 4 specialist theses on various rheumatology topics and presented his work at numerous national and international conferences, with 69 documented presentations. As an educator, he teaches doctoral courses on rheumatologic symptoms, extremity examination, and specific rheumatic conditions. His work bridges clinical practice, academic research, and digital health education, making significant contributions to rheumatology both nationally and internationally.

Serge Korjianمشاهده پروفایل

دانشگاهی

• Interventional Cardiology
• Clinical Trials
• Cardiovascular Research
• +۳ مورد دیگر

Dr. Serge Korjian is a prominent figure in clinical cardiology, currently serving as the Senior Medical Director of Clinical Trials and Director of the Angiographic Core Lab at the Baim Institute for Clinical Research. He is also an Instructor of Medicine at Harvard Medical School and an Attending Physician in Interventional Cardiology at Massachusetts General Hospital. His affiliations span leading institutions in cardiovascular research, including collaborations with Dr. C. Michael Gibson on international trials like APEX, AEGIS-I/II, PIONEER AF-PCI, and HEARTLINE. Dr. Korjian's research focuses on antiplatelet and anticoagulant therapies , lipid-modifying interventions , and novel devices for acute coronary syndromes . His expertise includes clinical trial design, protocol development, safety monitoring, and cardiovascular data analysis. Key contributions address residual risk in post-MI patients, cost-effectiveness of diagnostics, and bleeding prevention in AF-PCI cohorts. His recent publications highlight innovations in apolipoprotein A-I infusions , angiographic imaging , and risk prediction tools . Trends in his work emphasize patient-centric outcomes, digital trial recruitment, and the intersection of biomarkers (e.g., D-dimer, cholesterol efflux capacity) with clinical endpoints. While no formal scientific awards are disclosed in the text, his leadership in core labs and endpoint adjudication underscores his academic impact. Dr. Korjian's career bridges academic leadership with hands-on involvement in global clinical trials. He previously trained at the PERFUSE study group and Beth Israel Deaconess Medical Center , where he honed skills in interventional cardiology and statistical analysis. His current roles position him at the forefront of translational cardiovascular research and trial methodology.

Tommaso Goriمشاهده پروفایل

استاد

• Interventional Cardiology
• Coronary Physiology
• Intravascular Imaging
• +۳ مورد دیگر

Tommaso Gori serves as DZHK Professor for myocardial and vascular interactions at Johannes Gutenberg University Mainz's University Medical Center, where he practices as an interventional cardiologist specializing in coronary physiology, imaging, and pharmacology. His research program spans three interconnected domains: (1) coronary physiology with emphasis on microvascular dysfunction and myocardial ischemia mechanisms; (2) coronary anatomy analysis through invasive intravascular imaging; and (3) vascular pharmacology investigations. This work employs methodologies ranging from mechanistic laboratory studies to large-scale clinical trials with patient-centered endpoints. Analysis of his 2013-2019 publications reveals dominant focus on bioresorbable vascular scaffold complications—particularly stent thrombosis mechanisms analyzed via optical coherence tomography—with secondary exploration of environmental cardiovascular risk factors and nitrate pharmacology. Award highlights include: Caduceo d'Oro (best doctorate of the year 1997) Young Investigators Award, American College of Cardiology (2001) Young Investigators Award, American Heart Association (2001)

• Cardiology
• Cardiovascular Disease
• Interventional Cardiology
• +۴ مورد دیگر

Dr. Peter McCartney is an Honorary Clinical Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on coronary artery disease, myocardial infarction, and interventional cardiology, with particular expertise in coronary microvascular function and percutaneous coronary intervention (PCI) optimization. He has contributed to landmark trials like CorMicA and T-TIME, investigating stratified medical therapy and adjunctive therapies in cardiovascular conditions. His work spans clinical trials, systematic reviews, and meta-analyses, addressing topics such as coronary perforation management, stent optimization, and microvascular injury assessment. McCartney collaborates widely, including with colleagues at the University of Glasgow and international institutions, to advance diagnostic and therapeutic strategies in cardiovascular medicine. No scientific awards are explicitly mentioned in the provided materials. His publications emphasize patient outcomes, procedural improvements, and invasive coronary function testing. He has been involved in designing trials evaluating therapies like mineralocorticoid receptor antagonists and low-dose intracoronary alteplase. No specific grants or lab affiliations are detailed in the text.

• Emergency Medicine
• Cardiovascular Diseases
• Microvascular Angina
• +۱۳ مورد دیگر

Basmah Safdar, MD, is a Professor of Emergency Medicine at Yale School of Medicine, where she also serves as Vice Chair for Faculty Affairs and Development, Director of Women’s Health Research at Yale (WHRY), and Medical Director of the Chest Pain Center at Yale New Haven Hospital. She leads the Yale CMD Registry and Biorepository, focusing on sex and gender-specific research in microvascular health. Norma Weinberg Spungen and Joan L. Bildner Professor of Emergency Medicine Director, Women's Health Research at Yale Vice Chair for Faculty Affairs and Development, Emergency Medicine Medical Director, Chest Pain Center Dr. Safdar earned her MD from Aga Khan University, completed residency and chief residency at Yale New Haven Hospital, and holds an MSc in Cardiovascular Epidemiology from Harvard University. She is a 2024 Fellow of the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program. Her research centers on microvascular dysfunction in the heart, brain, and its implications in conditions like chest pain and COVID-19. She investigates sex-specific differences in cardiovascular disease, aiming to improve diagnosis, reduce healthcare disparities, and develop precision medicine approaches. Her work spans clinical trials, translational research, and biomarker discovery, with a strong emphasis on emergency medicine settings. Her recent publications highlight trends in identifying novel biomarkers (e.g., renalase), understanding systemic microvascular disease, addressing gender and race bias in healthcare, and advancing clinical diagnostics for coronary microvascular dysfunction. Her research integrates machine learning, epidemiology, and clinical cardiology to improve patient outcomes. Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM®) Program (2024) Women Executive Leadership Program, Impact Center (2022) AWAEM Midcareer Award, Society of Academic Emergency Medicine (2020) Momentum Leadership Award, Academy for Women in Emergency Medicine (2014) Best Clinical Science Research Award, Resident Category (2005) Dr. Safdar is deeply committed to mentorship and faculty development. She mentors medical students, residents, fellows, and junior faculty and led the national organization AWAEM as President. She has secured grants from the NIH, CDC, and foundations to support her research and leadership programs. She champions equitable clinical and academic systems, advocating for transparent advancement and compensation practices in emergency medicine. She leads the Safdar Lab, which conducts interdisciplinary research on sex and gender-specific microvascular health, collaborating with experts in cardiology, neurology, epidemiology, and biomedical data science. The lab leverages clinical data, biorepositories, and advanced analytics to drive innovation in women’s health and emergency care.

• Angina
• Cardiovascular medicine
• Chronic total occlusion
• +۵ مورد دیگر

Conjoint Associate Professor Tom Ford is an Interventional Cardiologist at the University of Newcastle's School of Medicine and Public Health. He serves as director of Central Heart on the Central Coast of NSW and holds appointments as the Australian National Young Ambassador to EAPCI (European Association for Percutaneous Coronary Intervention). He is also a Fellow of the Royal College of Physicians (Edinburgh) and Fellow of Cardiac Society for Australia/New Zealand (FCSANZ). Dr. Ford completed his medical training at the University of Dundee, receiving the University Medal (Captain WA Low Prize 2007). He gained the MRCP at the Royal College of Physicians in Edinburgh before emigrating to Australia in 2010. He completed his FRACP during advanced cardiology training at Prince of Wales Hospital and St George Hospital in Sydney. His subspecialty training included a three-year fellowship at Glasgow's Golden Jubilee National Hospital, the UK's highest volume center for coronary stents, where he also completed his PhD which won the prestigious Bellahouston Medal. Dr. Ford's research focuses on coronary physiology, interventional cardiology, and microvascular angina, with particular expertise in angina and ischemic heart disease. His work bridges clinical practice and research, investigating coronary vasomotor disorders, complex percutaneous coronary interventions, and chronic total occlusions. His recent publications demonstrate a strong emphasis on functional coronary angiography, coronary microvascular dysfunction assessment techniques, and the development of targeted therapies for microvascular disease. Dr. Ford has received significant recognition for his work including the Bellahouston Medal for his PhD thesis, EuroPCR Best Abstract award, and the British Cardiac Society's 'Best of the Best' Clinical Abstract award in Interventional Cardiology. His research has been published in leading cardiology journals and he has been invited faculty at major cardiology scientific sessions including the American Heart Association, European Society of Cardiology, EuroPCR, and Transcatheter Cardiovascular Therapeutics. Dr. Ford actively participates in multicenter clinical trials and registries including the CorMicA trial, TARGET-FFR study, and the Australian-New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry. His clinical practice combines advanced interventional techniques with a focus on diagnosing and managing patients with complex coronary conditions, particularly those with angina but without obstructive coronary artery disease.

• Cardiology
• Electrophysiology
• Hypertension
• +۵ مورد دیگر

Muammer Karakayali serves as an Assistant Professor in the Department of Internal Medicine at Kafkas University Faculty of Medicine, specializing in cardiology with a focus on electrophysiology, hypertension, and coronary artery disease. With over 100 publications and an h-index of 14 (Google Scholar), his research spans cardiac biomarkers, arrhythmia prediction, and post-COVID cardiac complications. PhD from Health Sciences University (2014-2019) Bachelor's Degree from Trakya University Faculty of Medicine (2008-2014) His research interests center on inflammatory biomarkers in cardiovascular disease, circadian blood pressure patterns, and cardiac manifestations of systemic conditions. Key areas include atrial fibrillation prediction using electrocardiographic parameters (P-wave peak time, QRS-T angle), MINOCA/INOCA pathophysiology, and risk stratification in acute coronary syndromes. His work employs advanced methodologies including speckle-tracking echocardiography and analysis of hematological indices. Karakayali leads the MORCOR-TURK LGI study on leuko-glycemic index in coronary care units and participates in the TRAFFIC Study on real-world atrial fibrillation management. His publication trends show increasing focus on post-COVID cardiac sequelae since 2020, with significant contributions to understanding arrhythmia mechanisms in inflammatory states. Young Cardiologists of the Year Award - First Place (2024) Dr. Ümit Aker Most Successful TKD Archive Article Awards (2024) He maintains extensive collaborations with 188 researchers including Timor Omar (43 joint publications) and İnanç Artaç (44 joint publications). His teaching portfolio includes 71 courses spanning EKG interpretation, pacemaker applications, and arrhythmia management across medical education levels. As an active member of the European Society of Cardiology (ESC ID: 852743) and European Heart Rhythm Association (Silver Member), he contributes to advancing clinical cardiology practice in Turkey.

• Interventional Cardiology
• Coronary Hemodynamics
• Percutaneous Coronary Intervention (PCI)
• +۳ مورد دیگر

George (Rick) Stouffer, MD, is the Ernest and Hazel Craige Distinguished Professor of Medicine in the Division of Cardiology and Professor of Biomedical Engineering at the University of North Carolina at Chapel Hill. His dual appointment bridges clinical cardiology and engineering, underlining a career focused on translating hemodynamic insights into improved patient care. Education & Training: While explicit educational credentials are not listed in the provided text, Dr. Stouffer’s academic rank and extensive scholarly output imply completion of medical school, internal-medicine residency, and cardiology fellowship, most likely at UNC-Chapel Hill or affiliated institutions. Research Focus: Dr. Stouffer’s work centers on interventional cardiology, coronary hemodynamics, and precision antiplatelet therapy guided by pharmacogenomics (especially CYP2C19 genotype). Additional themes include rural-urban cardiovascular disparities, mechanical circulatory support, and the hemodynamics of complex pericardial and valvular disorders. His recent publications integrate machine-learning models to predict ischemic outcomes and optimize PCI strategies. Recent Publication Landscape (2024–2025): Across 30+ papers released in 2024–2025, dominant trends include: rigorous assessment of hemodynamics in cardiogenic shock, intracoronary thrombolysis, percutaneous coronary interventions for chronic total occlusions, and real-world implementation of genotype-guided P2Y12 inhibitor therapy. A recurring motif is the evaluation of disparities—rural versus urban, Black versus non-Black patients—in both access and outcomes after PCI. Scientific Awards & Honors: The text explicitly mentions the Ernest and Hazel Craige Distinguished Professorship in Medicine as a named chair; no additional medals, fellowships, or society honors are detailed in the source provided. Advising & Grants: While the supplied material does not enumerate graduate students, post-docs, or funded-grant details, Dr. Stouffer’s prolific multi-institutional collaborations and registry-based studies (e.g., Precision PCI Registry) imply robust ongoing funding and a substantial mentoring role. Laboratory & Team: No specific laboratory name or team roster appears in the text; however, his cross-disciplinary appointment in both Cardiology and Biomedical Engineering suggests active collaboration with bioengineers, clinical interventionalists, and outcomes-research faculty at UNC.

• Cardiovascular Medicine
• Coronary Artery Disease
• Myocardial Infarction
• +۴ مورد دیگر

Dr David Corcoran is an Honorary Clinical Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health. His research focuses on coronary artery disease, post-COVID-19 cardiovascular outcomes, and cardiac imaging techniques. He has contributed to major trials like CorMicA, investigating coronary physiology and microvascular dysfunction. Dr. Corcoran’s work spans clinical trials (e.g., serelaxin’s vascular effects), post-pandemic health trajectories, and diagnostic innovations (e.g., automated myocardial blood flow analysis via MRI). He has published widely on angina management, myocardial infarction mechanisms, and multisystem post-viral complications. His research integrates imaging (CMR, MRI) with clinical practice to improve cardiovascular diagnostics and therapies. Research Interests: Coronary Microvascular Dysfunction, Post-COVID-19 Cardiovascular Effects, Cardiac Imaging, Fractional Flow Reserve (FFR), and Clinical Trial Design. Key Projects: CorMicA trial (coronary physiology stratification), CISCO-19 imaging study (COVID-19 cardiopulmonary effects), and CABG-ACS trials (invasive/non-invasive management). Publications: Over 50 peer-reviewed articles, emphasizing clinical trials, diagnostic advancements, and pandemic-related cardiovascular sequelae.

• Cardiovascular Diseases
• Diabetes
• Stem Cells
• +۳ مورد دیگر

Professor Martin Ng is an academic faculty member at the Sydney Medical School , University of Sydney, with a focus on cardiovascular diseases, diabetes, and bioengineering. His research spans both clinical and translational domains, emphasizing coronary microvascular function, transcatheter valve interventions, and angiogenesis regulation. Key Research Areas: Cardiovascular diseases, diabetes, stem cells, bioengineering, coronary artery disease, and angiogenesis. Recent Publications: 15 studies (2025–2022) cover transcatheter valve outcomes, microvascular resistance, mitral regurgitation staging, and molecular mechanisms in angiogenesis. Clinical Specialties: Cardiology, particularly coronary and valvular diseases. Collaborations: National Echo Database of Australia, multidisciplinary teams in interventional cardiology and bioengineering. Email: martin.ng@sydney.edu.au

• Cardiology
• Cardio-Oncology
• Medical Imaging
• +۳ مورد دیگر

Dr. Christopher Yu is a Clinical Lecturer at the Nepean Clinical School, part of the Sydney Medical School within the University of Sydney's Faculty of Medicine and Health. His research focuses on cardiovascular health, cardio-oncology, and medical imaging, particularly addressing cardiac complications from chemotherapy and improving diagnostic techniques for heart conditions. He has contributed to studies like the REDUCE trial (sonothrombolysis in myocardial infarction) and the AGILE-echo trial (AI-guided echocardiography in remote settings). His work bridges clinical practice and innovation, with recent publications exploring anthracycline cardiotoxicity, coronary artery imaging via AI (TQGDNet), and the role of cardiac MRI in diagnosing MINOCA (myocardial infarction with non-obstructive coronary arteries). He has also evaluated Australia’s cardio-oncology landscape and long-term outcomes of cardiac device-related complications. Key collaborations include studies on prophylactic strategies to mitigate cancer therapy-induced cardiac damage and optimizing pharmacotherapy cessation post-chemotherapy recovery. His research emphasizes translating advanced imaging and AI tools into clinical applications for better patient outcomes.

Susan Wrayمشاهده پروفایل

استاد

• Smooth muscle physiology
• Reproduction
• Cell signalling
• +۳ مورد دیگر

Susan Wray is a Professor of Cellular and Molecular Physiology at the School of Life Course and Medical Sciences, University of Liverpool. She serves as Director of the Centre for Better Births and Co-Director of the Harris/WoW Centre for Preterm Birth Research, focusing on uterine physiology to improve pregnancy outcomes globally. Her academic career spans over three decades at the University of Liverpool, where she was appointed to a personal chair in 1996 and served as Head of Department (2004-2008). University of Liverpool Centre for Better Births Harris/WoW Centre for Preterm Birth Research She is a Fellow of the Academy of Medical Sciences (2002) and the Royal College of Obstetricians and Gynaecologists (2006). She received the Joan Mott Prize Lecture (2006), a Wolfson Foundation Award (2009), and recognition as a Liverpool Knowledge Hero (2012). Her research bridges smooth muscle physiology, cell signaling, and obstetric challenges including preterm birth and obesity-related complications. Fellow of the Academy of Medical Sciences (FMedSci) Honorary Fellow of Royal College of Obstetricians and Gynaecologists (FRCOG) Joan Mott Prize Lecture (2006) Wolfson Foundation Award (2009) Liverpool Knowledge Hero (Echo, 2012) Wray's work includes extensive grant funding from organizations like the British Heart Foundation, Wellcome Trust, Medical Research Council, and Department of Health & Social Care. She has supervised numerous PhD students, exploring topics such as extracellular acidification, hypoxia, hydrogen sulfide, and prostaglandin effects on uterine contractility. She is a dedicated advocate for gender equality, serving as the University’s Director for Gender Equality via the Athena SWAN Charter. A skilled communicator, she has appeared on BBC Radio 5 Live, Woman’s Hour, and contributes to public science through media engagement and the BA Festival of Science presentation 'Womb Wars'.

Navid Freidoonimehrمشاهده پروفایل

پژوهشگر ارشد

• Biofluid Mechanics
• Coronary Haemodynamics
• Computational Fluid Dynamics
• +۳ مورد دیگر

Dr. Navid Freidoonimehr is a Research Fellow at Queensland University of Technology (QUT), affiliated with the School of Mechanical, Medical and Process Engineering and the Centre for Biomedical Technologies. Holding a PhD from the University of Adelaide, his work bridges biofluid mechanics , cardiovascular diagnostics , and energy-efficient fluid systems . Education: PhD (University of Adelaide) Professional Memberships: Australian Fluid Mechanics Society, American Society of Mechanical Engineers, Engineers Australia, European Society of Biomechanics His research focuses on coronary artery disease and microvascular dysfunction , combining experimental fluid mechanics with computational fluid dynamics (CFD) to analyze blood flow patterns, stent performance, and novel diagnostic indices. Notable projects include developing a CFD-based resistance index for microvascular spasm (2024-2025) and exploring flow pulsation energy savings in pipelines under his 2025 ARC DECRA grant. Recent publications highlight his expertise in hemodynamic modeling , turbulent boundary layers , and biofluid-structure interactions . Awards include the Heart Foundation Postdoctoral Fellowship and Vanguard Grant . He actively supervises PhD students in collaboration with leading researchers like Professor Zhiyong Li.

Chim Langمشاهده پروفایل

استاد بالینی

• Cardiology
• Clinical Pharmacology
• Cardio-metabolic Diseases
• +۹ مورد دیگر

Professor Chim Lang is a Clinical Professor of Cardiology in the School of Medicine at the University of Dundee, affiliated with Ninewells Hospital and Medical School, UK. He is a consultant cardiologist and clinical pharmacologist with extensive international training, including fellowships at Vanderbilt and Columbia Universities. He holds fellowships from the Royal Society of Edinburgh, Royal Colleges of Physicians, American College of Cardiology, and European Society of Cardiology. University: University of Dundee School: School of Medicine Department: Cardiovascular Research Academic Rank: Clinical Professor Email: C.C.Lang@dundee.ac.uk Professor Lang earned his BSc, MBBS, and MD from the University of Dundee, focusing on neurohormones and sodium homeostasis. His research expertise lies in cardio-metabolic diseases, with a multidisciplinary approach integrating pathophysiology, pharmacogenetics, and translational medicine. He leads a cardiovascular research laboratory focused on cardiac and vasomotor regulation, biomarker development, and novel therapeutic strategies. His recent publications highlight cutting-edge work in AI-based prediction of heart failure from retinal images, genetic risk profiling in aortic stenosis, neutrophil extracellular traps in HFpEF, and clinical trials such as REACH-HFpEF and CARDIATEAM. These studies reflect a strong trend toward precision medicine, digital health, and population-level informatics in cardiovascular care. Fellow of the Royal Society of Edinburgh (FRSE) Fellow of Royal Colleges of Physicians (London and Edinburgh) Fellow of American College of Cardiology Fellow of European Society of Cardiology British Pharmacological Society BrAPP Prize and Medal (1993) Fulbright Scholarship (2001) American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award (1995) Professor Lang has supervised 25 MD/PhD students and serves as an external examiner across multiple UK and Southeast Asian universities. He is Chief Investigator for major trials including MET-REMODEL, RECEDE, REFORM, and REACH-HFpEF, and leads the MRC UK-Malaysia PRIME project. His work has directly influenced clinical guidelines and FDA decisions, with two 4-star REF 2014 impact cases and recognition in REF 2021. He is also the UK National Coordinator for international trials such as COMMANDER-HF, ARISE, and SELECT. He leads or contributes to active research projects in multimorbidity in aging cancer patients, diabetes phenotyping (iDiabetes), and diabetic cardiomyopathy (CARDIATEAM), often in collaboration with international consortia and funded by BHF, MRC, NIHR, and EU programs.

Jessica Filosaمشاهده پروفایل

استاد

• Neurovascular coupling
• Neuroscience
• Cardiovascular physiology
• +۷ مورد دیگر

Jessica Filosa is a Professor in the Department of Physiology at the Medical College of Georgia, Augusta University. She holds a primary academic appointment in the Department of Physiology and a secondary appointment in The Graduate School. Dr. Filosa has been with Augusta University since 2008, progressing from Assistant Professor to Associate Professor and finally to her current position as Professor since 2019. Prior to this, she served as Assistant Professor and Research Assistant Professor in the Department of Psychiatry at the University of Cincinnati (2004-2008). Dr. Filosa earned her Ph.D. in Biomedical Sciences from Wright State University in 2002 and her M.S. in Biology from Emporia State University in 1997. Her educational background laid the foundation for her current research program focused on neurovascular communication. Dr. Filosa's research centers on understanding the signaling mechanisms governing bi-directional communication among various cell types within the brain, with particular emphasis on neuron-glial-vascular interactions. Her laboratory investigates three main areas: (1) characterizing the intrinsic properties of parenchymal arterioles in the brain, (2) examining neuron-glial-vascular communication in specialized brain regions including the somatosensory cortex, supraoptic nucleus, and hypothalamus, and (3) determining how disruptions in neuroglial-vascular crosstalk contribute to cerebrovascular disorders such as hypertension and stroke. Using advanced techniques including electrophysiological recordings, Ca 2+ imaging, and immunohistochemistry, her work bridges neuroscience with cardiovascular physiology to address pathologies involving both vascular and neuronal deterioration. Analysis of Dr. Filosa's recent publications reveals a strong focus on neurovascular coupling mechanisms, particularly how blood pressure variability affects cerebrovascular function and cognitive outcomes. Her research increasingly examines the role of specific molecular pathways (such as ADAM17) in Alzheimer's disease models and explores the connections between hypertension, cerebrovascular dysfunction, and cognitive impairment. The work demonstrates a progression from basic mechanisms of neurovascular communication toward translational applications for understanding and treating cerebrovascular disorders. Participant in an NIH Study (2023) Hamilton Scholar in Physiology, Department of Physiology, Augusta University (2017) Outstanding Young Research Scientist, Georgia Health Sciences University (2012) Multidisciplinary approaches for neurogenic hypertension research (2011) Functional Hyperemia in the Brain: APS Latin-American Initiative (2008) Dr. Filosa has mentored graduate students including Jennifer Iddings (2010-2015) and currently oversees a research team comprising Perenkita Mendiola (Postdoctoral Fellow) and Adriana Langer Gramer (Research Assistant). She serves on numerous grant review committees including the Intramural Grants Programs (2017-present) and Basic Science Advisory Council (2018-present). Her professional service includes NIH Study Section reviewing (2021), membership on the Scientific Advisory Committee for the International Symposium on Resistance Arteries (2020), and reviewing for the International Society for Cerebral Blood Flow & Metabolism. Dr. Filosa teaches multiple advanced physiology courses including Medical Neurophysiology, Medical Physiology II, and Neuroscience I, demonstrating her commitment to both research and education in the field of physiology.